no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Bone Pain Associated with Once-Per-Cycle Pegfilgrastim Is Similar to Daily Filgrastim in Patients with Breast Cancer
|
Kubista, Ernst |
|
2003 |
3 |
6 |
p. 391-398 8 p. |
article |
2 |
Capecitabine/Bevacizumab Compared to Capecitabine Alone in Pretreated Metastatic Breast Cancer: Results of a Phase III Study)
|
Maung, Kavita |
|
2003 |
3 |
6 |
p. 375-377 3 p. |
article |
3 |
Chemotherapy for Breast Cancer: What's New? What's Useful?
|
George Jr., George W. |
|
2003 |
3 |
6 |
p. 367- 1 p. |
article |
4 |
E2100: A Phase III Trial of Paclitaxel Versus Paclitaxel/Bevacizumab for Metastatic Breast Cancer
|
Miller, Kathy D. |
|
2003 |
3 |
6 |
p. 421-422 2 p. |
article |
5 |
Improved Disease-Free and Overall Survival with Dose-Dense Chemotherapy Compared with Conventional Chemotherapy in the Adjuvant Treatment of Node-Positive Breast Cancer: Results of a Randomized Study (CALGB 9741)
|
Maung, Kavita |
|
2003 |
3 |
6 |
p. 372-374 3 p. |
article |
6 |
Inhibiting Ras Signaling in the Therapy of Breast Cancer
|
Li, Tianhong |
|
2003 |
3 |
6 |
p. 405-416 12 p. |
article |
7 |
Prognostic and Predictive Indicators in Operable Breast Cancer
|
Morabito, Alessandro |
|
2003 |
3 |
6 |
p. 381-390 10 p. |
article |
8 |
The Addition of Carboplatin to Trastuzumab/Paclitaxel Improves Efficacy in HER2-Overexpressing Metastatic Breast Cancer
|
D'Orazio, Amy |
|
2003 |
3 |
6 |
p. 378-380 3 p. |
article |
9 |
The Future of Breast Cancer Therapy: Erythropoietin as an Integral Component
|
Leyland-Jones, Brian |
|
2003 |
3 |
6 |
p. 417-420 4 p. |
article |
10 |
Vinorelbine as a 96-Hour Continuous Infusion in Heavily Pretreated Patients with Metastatic Breast Cancer: A Cooperative Study by the GEICAM Group
|
Jara-Sánchez, Carlos |
|
2003 |
3 |
6 |
p. 399-404 6 p. |
article |